Spermotile cultivates hope one star-sperm at a time. It is a revolutionary med-tech device that selects the star sperm and improves IVF success rates by 50%.

At present Spermotile is an innovation family housed at UiT The Arctic University of Norway and well funded by public funding (4M Euros till 2027). We will have CE mark, FDA, and first beta customers by then. We will be fundraising in 2026/2027 but we see no harm in early discussions as well.